Document Detail


Angiographic Demonstration of Neoangiogenesis After Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Diabetic Patients With Critical Limb Ischemia.
MedLine Citation:
PMID:  22289660     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Critical limb ischemia in diabetic patients is associated with high rates of morbidity and mortality. Suboptimal responses to the available medical and surgical treatments are common in these patients, who also demonstrate limited vascular homeostasis. Neovasculogenesis induced by stem cell therapy could be a useful approach for these patients. Neovasculogenesis and clinical improvement were compared at baseline and at 3 and 12 months after autologous bone marrow-derived mononuclear cell (BMMNC) transplantation in diabetic patients with peripheral artery disease. We conducted a prospective study to evaluate the safety and efficacy of intra-arterial administration of autologous BMMNCs (100-400 × 10(6) cells) in 20 diabetic patients with severe below-the-knee arterial ischemia. Although the time course of clinical effects differed among patients, after 12 months of follow-up all patients presented a notable improvement in the Rutherford-Becker classification, the University of Texas diabetic wound scales, and the Ankle-Brachial Index in the target limb. The clinical outcome was consistent with neovasculogenesis, which was assessed at 3 months by digital subtraction angiography and quantified by MetaMorph software. Unfortunately, local cell therapy in the target limb had no beneficial effect on the high mortality rate in these patients. In diabetic patients with critical limb ischemia, intra-arterial perfusion of BMMNCs is a safe procedure that generates a significant increase in the vascular network in ischemic areas and promotes remarkable clinical improvement.
Authors:
Rafael Ruiz-Salmeron; Antonio de la Cuesta-Diaz; Manuel Constantino-Bermejo; Immaculada Pérez-Camacho; Francisco Marcos-Sánchez; Abdelkrim Hmadcha; Bernat Soria
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cell transplantation     Volume:  20     ISSN:  1555-3892     ISO Abbreviation:  Cell Transplant     Publication Date:  2011  
Date Detail:
Created Date:  2012-01-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9208854     Medline TA:  Cell Transplant     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1629-39     Citation Subset:  IM    
Affiliation:
Hospitales Universitarios San Lázaro and Virgen Macarena, Sevilla, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in hea...
Next Document:  5-HT and physical illness.